1)社団法人日本消化器がん検診学会.平成18年度消化器がん検診全国集計資料集.2008
2)濱島ちさと.胃がん検診ガイドラインと今後の課題.胃と腸 43 : 1139-1145, 2008
3)細川治,山崎信,津田昇志,他.胃癌診断方法の変化に伴う間接レントゲン読影技術習得の問題点.消集検 31 : 50-54, 1993
4)細川治.胃癌診断方法の転換と胃集団検診.消集検 33 : 195-198, 1995
5)深尾彰,濱島ちさと,渋谷大助,他.有効性評価に基づく胃がん検診ガイドライン(普及版).癌と化療 33 : 1183-1197, 2006
6)Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol 4 : 709-716, 2006
7)鵜浦雅志,米島博嗣,池田直樹.石川県羽咋市のペプシノゲン検査を併用した胃がん検診成績.日消がん検診誌 44 : 459-464, 2006
8)乾純和,吉川守也,安部純,他.住民検診においてHelicobacter pylori検査はどのように活用されるか─血清H. pylori抗体価,血清ペプシノゲン値同時測定による胃がん検診(ABC検診)の試み.Helicobacter Res 11 : 554-561, 2007
9)Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1 : 87-97, 1969
10)Hosokawa O, Watanabe K, Hatorri M, et al. Detection of gastric cancer by repeat endoscopy within a short time after negative examination. Endoscopy 33 : 301-305, 2001
11)細川治,山崎信,山道昇,他.早期胃癌における性差の検討.消外 11 : 1269-1272, 1988
12)Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status : a prospective endoscopic cohort study. Gut 54 : 764-768, 2005
13)Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 109 : 138-143, 2004
14)Farinati F, Rugge M, Mario F, et al. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D─International Group on Gastric Epithelial Dysplasia Endoscopy 25 : 261-264, 1993
15)渕上忠彦,岩下明徳,堺勇二,他.胃良・悪性境界病変(Group III病変)の長期経過からみた生検診断の問題点.胃と腸 29 : 153-168, 1994
16)Hansson LE, Nyr始 O, Hsing Aw, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335 : 242-249, 1996
17)細川治,山崎信,津田昇治,他.併存胃潰瘍を有する早期胃癌症例の検討.外科診療 34 : 1075-1079, 1992